The Fort Worth Press - A US farm breeds pigs for human kidney transplants

USD -
AED 3.673024
AFN 70.172432
ALL 93.596763
AMD 393.041789
ANG 1.800333
AOA 912.388974
ARS 1020.504904
AUD 1.581155
AWG 1.8
AZN 1.70406
BAM 1.862259
BBD 2.016948
BDT 119.373851
BGN 1.862506
BHD 0.377073
BIF 2952.736413
BMD 1
BND 1.34945
BOB 6.903118
BRL 6.104964
BSD 0.998905
BTN 84.857227
BWP 13.647227
BYN 3.269126
BYR 19600
BZD 2.013521
CAD 1.431865
CDF 2870.00025
CHF 0.89278
CLF 0.035795
CLP 987.694157
CNY 7.285034
CNH 7.290375
COP 4345.53
CRC 502.832659
CUC 1
CUP 26.5
CVE 104.989788
CZK 23.884977
DJF 177.890978
DKK 7.10378
DOP 60.633183
DZD 133.958688
EGP 50.780902
ERN 15
ETB 126.863794
EUR 0.952285
FJD 2.323966
FKP 0.791982
GBP 0.787253
GEL 2.809664
GGP 0.791982
GHS 14.684402
GIP 0.791982
GMD 71.999716
GNF 8627.30536
GTQ 7.694212
GYD 208.997858
HKD 7.769585
HNL 25.353011
HRK 7.172906
HTG 130.59499
HUF 389.889357
IDR 16109.85
ILS 3.597195
IMP 0.791982
INR 84.903799
IQD 1308.665721
IRR 42087.501827
ISK 137.790182
JEP 0.791982
JMD 156.343728
JOD 0.709401
JPY 153.687502
KES 129.11027
KGS 87.000061
KHR 4014.205871
KMF 466.125033
KPW 899.999441
KRW 1435.769826
KWD 0.30756
KYD 0.832484
KZT 523.618636
LAK 21880.81715
LBP 89455.177339
LKR 290.849191
LRD 180.80457
LSL 18.059291
LTL 2.95274
LVL 0.60489
LYD 4.88836
MAD 9.991621
MDL 18.285431
MGA 4681.742442
MKD 58.59189
MMK 3247.960992
MNT 3397.99987
MOP 7.993868
MRU 39.711497
MUR 46.5318
MVR 15.354668
MWK 1732.15901
MXN 20.18503
MYR 4.470281
MZN 63.900855
NAD 18.059377
NGN 1552.302967
NIO 36.761625
NOK 11.195399
NPR 135.774339
NZD 1.739887
OMR 0.384993
PAB 0.998924
PEN 3.733087
PGK 4.045549
PHP 59.018499
PKR 277.905356
PLN 4.065804
PYG 7809.56915
QAR 3.642111
RON 4.737802
RSD 111.384973
RUB 104.600537
RWF 1391.478219
SAR 3.757585
SBD 8.383555
SCR 14.111832
SDG 601.501169
SEK 10.955655
SGD 1.350598
SHP 0.791982
SLE 22.807217
SLL 20969.503029
SOS 570.911688
SRD 35.204999
STD 20697.981008
SVC 8.740942
SYP 2512.530243
SZL 18.052845
THB 34.221498
TJS 10.913609
TMT 3.51
TND 3.170042
TOP 2.342098
TRY 35.013515
TTD 6.783244
TWD 32.517504
TZS 2353.744008
UAH 41.829374
UGX 3636.346324
UYU 44.531406
UZS 12856.231492
VES 50.47905
VND 25450
VUV 118.722003
WST 2.762788
XAF 624.572245
XAG 0.032842
XAU 0.000378
XCD 2.70255
XDR 0.762009
XOF 624.572245
XPF 113.556078
YER 250.375051
ZAR 18.087765
ZMK 9001.196067
ZMW 27.695311
ZWL 321.999592
  • RBGPF

    62.4900

    62.49

    +100%

  • RYCEF

    0.0600

    7.43

    +0.81%

  • RELX

    0.0400

    47.02

    +0.09%

  • CMSC

    0.0000

    24.32

    0%

  • NGG

    0.6100

    59.4

    +1.03%

  • GSK

    0.6500

    34.23

    +1.9%

  • SCS

    -0.2600

    13.05

    -1.99%

  • BTI

    -0.3500

    37.29

    -0.94%

  • CMSD

    -0.0400

    23.93

    -0.17%

  • BP

    0.1300

    29.08

    +0.45%

  • RIO

    0.2000

    61.46

    +0.33%

  • JRI

    -0.3800

    12.62

    -3.01%

  • BCC

    -3.1400

    133.11

    -2.36%

  • AZN

    0.9500

    67.18

    +1.41%

  • VOD

    0.0600

    8.63

    +0.7%

  • BCE

    -0.2800

    23.58

    -1.19%

A US farm breeds pigs for human kidney transplants
A US farm breeds pigs for human kidney transplants / Photo: © AFP

A US farm breeds pigs for human kidney transplants

On a farm in the southern US state of Virginia, David Ayares and his research teams are breeding genetically modified pigs to transplant their organs into human patients.

Text size:

Revivicor, the biotech company Ayares leads, is at the forefront of xenotransplantation research -- the implantation of animal organs into humans -- which aims to solve a chronic organ shortage that has thousands of Americans dying each year.

It was on this farm that Revivicor bred a pig whose kidney was recently transplanted into patient Towana Looney, according to an announcement made Tuesday by a New York hospital.

"It's just an exciting time," Ayares told AFP during a recent tour of the research farm.

The pigs are genetically modified to make their organs less likely to be rejected by patients' immune systems.

"These pigs are not typical farm pigs," said Ayares, as he cradled several pink piglets in his arms. "Millions of dollars have gone into the production of these genetics, and so they're very high-value animals."

The kidneys may one day sell for $1 million.

For more than 20 years, Revivicor in Blacksburg, Virginia has been conducting research to turn pig-to-human transplantation from science fiction to life-saving medical care.

In the United States alone, more than 100,000 people are on the transplant list and thousands die every year waiting, most often for a kidney, according to health authorities.

- 'Little room for recognition' -

Since 2021, several US surgeons have successfully transplanted genetically modified pig kidneys and hearts into humans, most of them supplied by Revivicor. Another key provider is the biotech firm eGenesis.

The first trials were carried out on brain-dead people, before the procedure was attempted on a handful of seriously ill patients.

While those patients died within weeks of the operation, the animal organs they received were not immediately rejected by their immune systems, which scientists hailed as a promising sign.

In a dark laboratory several kilometers away from the research farm, Todd Vaught, head of cell biology at Revivicor, has his eyes glued to a microscope.

With a pipette, he pierces a pig egg to remove its DNA and replace it with cells that have "all the instructions needed to make a genetically modified pig."

A few hours later, the edited eggs are implanted into sows. Four months later new litters are born.

While xenotransplantation research is happening in various parts of the world, the United States is a clear leader in the field.

French sociologist Catherine Rene criticized what she characterizes as mistreatment of the pigs as merely vessels for organs destined for humans.

"Ultimately, there is very little room for recognition of the donor animal, of the gift that is made," Rene told AFP.

Ayares disagreed.

"Hundreds of millions of pigs are used every year as food," Ayares said. "I would argue that this is a much higher calling for that pig organ to be used for transplantation."

- Million dollar price tag -

The first line of pigs developed by Revivicor carried only one genome edit meant to deactivate the animal's production of a substance that causes people to reject the transplanted organ.

The second has 10 modified genes, six of which come from human DNA in order to improve biological compatibility.

It is with this second line of pigs that United Therapeutics (UT), Revivicor's parent company, is thinking big.

In March, the publicly traded company opened another medical facility near Blacksburg where, in a brand-new operating room, pigs' kidneys will be removed and prepared for transfer to the receiving patient.

The rest of the pig will be discarded.

Spokesman Dewey Steadman said the facility has "rigorous controls" in place to prevent any infection of the 200 animals being kept there.

The company's goal is to begin several years of clinical studies on patients in 2025 and, if the Food and Drug Administration gives the green light, to begin full-scale production of genetically modified pigs in 2029.

UT is already planning to invest billions of dollars into building more and bigger facilities.

The company is considering selling kidneys for around $1 million each, which is close to the cost of 10 years of dialysis for patients in the United States, according to Steadman.

Making pig kidneys available to a large number of patients will not be an easy task in the United States, which lacks universal health care.

But Ayares hopes that with health insurance, "the patient is not bearing a million dollars... price tag."

P.Grant--TFWP